We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Mobile System Captures and Manages ECG Data

By HospiMedica International staff writers
Posted on 24 Jun 2015
A novel cloud-based healthcare IT platform enables physicians, nurses, and care providers to capture, review, and annotate patient 12-lead electrocardiogram (ECG) tracings. More...


The InvisionHeart ECG System is a mobile, cost-effective, technological solution for capturing and managing 12-lead ECGs, including the ability to read and visually compare, confirm, report, and store diagnostic quality readings. A proprietary high resolution 12-lead ECG device with an intuitive capture system is first used to record the ECG. The data is then transmitted to InvisionConnect, a secure cloud-based platform that allows a network of physicians, nurses, and technicians, to securely access and interpret patient the ECG readings.

Credentialed users can access ECGs from any web-enabled device, and additional cloud-based tools, such as messaging and notifications, help in the timely evaluation of patient ECGs. A web-based application with enhanced diagnostic tools assists in the review and formal diagnosis of patient ECGs, and integrates with electronic medical record systems (EMRs). The InvisionHeart ECG System is a product of InvisionHeart (Nashville, TN, USA), and has been approved by the US Food and Drug Administration (FDA).

“Initial interest has been strong from a broad array of potential users, especially those challenged to find a high-quality, low-cost solution that is secure and fully electronic,” said Melanie Varin, executive vice president of sales and marketing at InvisionHeart. “In addition to hospitals, we’ve detected genuine enthusiasm from the rapidly growing markets for home health and ambulatory care as well as other specialty markets.”

“This is a significant milestone in the development of our technology and, more importantly, a breakthrough in our ability to serve patients where ECGs have been traditionally unavailable,” said Josh Nickols, PhD, President and CEO of InvisionHeart. “Earlier diagnosis of cardiac issues via improved access will benefit patients, whether in the hospital setting or at home.”

In a conventional 12-lead ECG, electrodes are placed on the patient's limbs and on the surface of the chest. The overall magnitude of the heart's electrical potential is then measured from twelve different angles and is recorded over a period of time (usually 10 seconds). The heart's electrical depolarization is thus captured at each moment throughout the cardiac cycle, displayed as a graph representing of voltage versus time, i.e., the ECG.

Related Links:

InvisionHeart



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
12-Channel ECG
CM1200B
New
Cervical Seal
Omni Lok
New
Multifunctional Patient Floor Lift
Maxi Move 5
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: A mechanosensing-based approach offers a potential path to the treatment for cardiac fibrosis (Photo courtesy of Adobe Stock)

Mechanosensing-Based Approach Offers Promising Strategy to Treat Cardiovascular Fibrosis

Cardiac fibrosis, which involves the stiffening and scarring of heart tissue, is a fundamental feature of nearly every type of heart disease, from acute ischemic injuries to genetic cardiomyopathies.... Read more

Surgical Techniques

view channel
Image: Bioprinting synthetic vasculature could dramatically change how cardiovascular diseases are treated (Dell, A.C., Maresca, J., Davis, B.A. et al.; doi.org/10.1038/s41598-025-93276-y)

Bioprinted Aortas Offer New Hope for Vascular Repair

Current treatment options for severe cardiovascular diseases include using grafts made from a patient's own tissue (autologous) or synthetic materials. However, autologous grafts require invasive surgery... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.